Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07611201 · ClinicalTrials.gov registry record
The Effects of GLP-1 Receptor Agonists on Chemosensory Function and Ingestive Behavior
A clinical trial, sponsored by Purdue University.
- Completed
- Registry status
- 90
- Enrollment target
NCT07611201 is a clinical trial that has completed, run by Purdue University. The registered enrollment target is 90 participants.
The verdict
NCT07611201 has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
The goal of this study is to explore whether of GLP-1 receptor agonist use is associated with differences in taste, smell, food preferences, appetite, food cravings, and responses to food cues in adults. The study includes adults who are not currently taking a GLP-1 receptor agonist but may be eligible to use one, and adults who are already taking a GLP-1 receptor agonist as part of their regular medical care for approximately 1 month or approximately 6 months. The main questions it aims to answer are: Are taste and smell function different among adults who are not taking a GLP-1 receptor agonist and adults who have been taking one for different lengths of time? Are food preferences, appetite, food cravings, food reward, attention to food cues, and salivary responses to food cues different among these groups? Researchers will compare adults not currently taking a GLP-1 receptor agonist with adults taking a GLP-1 receptor agonist for approximately 1 month or approximately 6 months. The research team will not prescribe, assign, or provide GLP-1 receptor agonist medications. People in the study will attend two in-person study visits, complete taste and smell tests, complete food preference and computer-based tasks, and provide saliva samples during a food cue task. Questionnaires about appetite, cravings, food cues, and eating behavior will be completed at home over approximately 2 weeks.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2025-02-20 |
| Est. Completion | 2026-05-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07611201
The ClinicalTrials.gov registry entry for NCT07611201 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Purdue University, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07611201 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07611201 about?
NCT07611201 is a clinical study titled "The Effects of GLP-1 Receptor Agonists on Chemosensory Function and Ingestive Behavior". The goal of this study is to explore whether of GLP-1 receptor agonist use is associated with differences in taste, smell, food preferences, appetite, food cravings, and responses to food cues in adults. The study includes adults who are not currently taking a GLP-1 receptor agonist but may be eligi...
What is the current status of trial NCT07611201?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2025-02-20. Estimated completion is 2026-05-04.
Who is sponsoring clinical trial NCT07611201?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.